Clinical pharmacology of RU 486—an antiprogestin and antiglucocorticoid
- 30 November 1993
- journal article
- review article
- Published by Elsevier in Contraception
- Vol. 48 (5), 403-444
- https://doi.org/10.1016/0010-7824(93)90133-r
Abstract
No abstract availableThis publication has 89 references indexed in Scilit:
- A Single Amino Acid That Determines the Sensitivity of Progesterone Receptors to RU486Science, 1992
- Alternative treatments in oral postcoital contraception: interim resultsAdvances in Contraception, 1991
- The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Voluntary Interruption of Pregnancy with Mifepristone (RU 486) and a Prostaglandin AnalogueNew England Journal of Medicine, 1990
- Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortionBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Pharmacokinetics and metabolism of RU 486Journal of Steroid Biochemistry, 1987
- The Progesterone Antagonist RU 486New England Journal of Medicine, 1987
- Synthesis of antiprogestational steroidsJournal of Steroid Biochemistry, 1987
- Termination of Early Pregnancy by the Progesterone Antagonist RU 486 (Mifepristone)New England Journal of Medicine, 1986
- Hydrocephalus and abnormal digits after failed first-trimester prostaglandin abortion attemptThe Journal of Pediatrics, 1983